Current practice in immunotherapy of sepsis 

(online survey study)

Survey was prepared on behalf of the BeatSepsis Consortium.

Dear colleagues! 

The aim of this survey is to map the actual current clinical approach to immunotherapy in patients with sepsis and septic shock.

We would be very grateful if you would support our efforts and complete the questionnaire. Your input might be helpful for designing future studies and possible implementation of this treatment in clinical practice.

Targeted Immunotherapy is undoubtedly the future in the treatment of sepsis. However, to date, there is a lack of sufficient data from large randomized trials to clearly recommend the routine use of specific immunomodulatory drugs. Even the Surviving Sepsis Campaign does not recommend the administration of specific therapies other than corticosteroids.

Despite this, immunotherapy is already routinely administered by many clinicians! The aim of this questionnaire study is to describe what is the realistic approach of clinical departments to the administration of such specific therapies.

We would like to collect data from all over the world to compare clinical practice in different countries.

Target group

The questionnaire is addressed to all hospital-based physicians who are practically involved in the care of patients with sepsis - i.e. to the following specialties: intensive care and resuscitation, emergency medicine, internal medicine, surgery, infectiology. We are interested in data from both adult and paediatric departments.



Content of this survey

This survey consist of two parts:

• questions to gain some background information about you and your department,
• questions aimed at your department´s experience with immunotherapy and use of corticosteroids in sepsis.

Participation will take no more than 10 minutes to complete.



Contact information

For questions about this survey, please contact the researchers via email sepsis.immunotherapy@fnusa.cz

Participating in the survey

By indicating that you agree to participate in this survey, you agree to the following:

• I have read the information about this survey;
• I understand that participation in the survey is voluntary and that I can stop at any time;
• I understand that background information cannot be traced back to individual persons (such as my profession or length of experience); 
  
• I understand that only background information (specified above) will be collected;
• I understand that survey data will be analyzed and reported anonymously, this way personal data of the survey participants are not processed within the meaning of the law, i.e. GDPR and the Personal Data Processing Act No.110/2019 Coll.
  

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

Thank you very much!

On behalf of the author's scientific team, with respect,

Martin Helán, Jakub Fischer

* Department of Anaesthesiology and Intensive Care Medicine, St. Anne's University Hospital in Brno, Czech Republic.

* International Clinical Research Centre, Brno, Czech Republic.

* Faculty of Medicine, Masaryk University, Brno, Czech Republic.

* BEATSEPSIS - International consortium for sepsis survivorship.